MRNA trade ideas
Bullish Crossover for MRNA Share Appears in the HorizonModerna's share (MRNA) price has been running in a narrow price range since November 8 after a series of gains extending since October 21, surpassing the short and long-term exponential moving averages in a positive short-term sign. Meanwhile, an unclear zigzag path has dominated MRNA share since the beginning of the year.
As for now, and on the daily chart, we keep an eye on 180.13 and $198.82 as possible bullish targets, as we await the bullish crossover of the MA-25 and MA-50 to achieve the possible bullish path.
On the flip side, if MRNA share price fails to stabilize above the $162 level, the previous bullish hypothesis may be invalidated, and we may witness a pullback towards $142-135 levels (yellow shaded area).
The HERCULES portfolioIt's time to keep a close eye on HERCULES portfolio stocks to be ready to reposition once the rules I've outlined in my post “A trading system for rookies” are met.
I also urge you to consider positions in the Greek Stock Exchange where there are now many reliable and safe stocks that are in a mature phase of rise.
Some of them are presented below. For more information you can search the recent reports of major investment houses Morgan Stanley, JP Morgan and others.
Also take a look at my post “Is the Greek stock market ready to skyrocket?”.
Never EasyCup & Handle
This broke out and experienced a throwback.
The throwback sent it back down to below long entry level.
Volatile but we trade at our own risk.
It does seem this is a stock one should slip in and out of, collect profit and move on, but who knows?
Throwbacks differ from pull backs. Pull backs are natural and are considered healthy.
Throwbacks can hurt performance and occur when a security has issues holding on to the break out price and throw back to beneath the long entry level in a quick manner.
No recommendation.
This does look like a CUP with a rounded bottom and does not have a pointy W at the bottom of the cup that I can see. Any pattern can fail/price is just below the .618 of the trend up.
MRNA - Short Initiated
April '23 130 Puts.
Been waiting for this trend line to be hit.
Setup the notification a few weeks ago - did not pay attention to it, TV worked perfectly - notified at 3:45PM on Friday, as you would expect.
This company (krime org) which has been funded through the US D_o_D. Yes it's all misspelt.
Which sounds crazy - but hear me out. Watch the video below.
rumble.com
Likely you can get in Monday - this is the top of the regression channel.
One Hour chart.
Moderna about to explode?Price has been testing the mayor resistance for a year, and trading for a month just there below it ready to test it out again. I think this time is going to break it. I have a small position and a wide stop loss. If the price breaks through and closes the week above the resistance, ~204 level, I'll add.
MRNA gaps up & down on newsModerna (MRNA) gaps up & down so much on news. As you can see from the ATR (average true range), + or - $20 moves are routine and + or - $40-$60 moves are not abnormal, from one day to the next. On the rare occasion MRNA is trading sideways for the day, I see that as an opportunity to enter a delta neutral position 1 ATR strike apart from the current price. For example, if MRNA is trading at $250, then a 1 ATR delta neutral position is a $230 put and a $270 call 12/17 expiry, otherwise known as an otm strangle. There are website based options profit / loss calculators that will do the black scholes calculations of IV, delta, theta, gamma and vega.
price levels on the 1d chart:
FibEMA233 = $248.09
FibEMA144 = $309.11
FibEMA89 = $348.33
FibEMA55 = $309.11
Trend channel
breakout = $370.13
R3 = $351.24
R2 = $330.90
R1 = $309.11
pivot = $290.22
S1 = $269.88
S2 = $249.54
S3 = $229.20
breakdown = $207.40
Do your own due diligence, your risk is 100% your responsibility. This is for educational and entertainment purposes only. You win some or you learn some. Consider being charitable with some of your profit to help humankind. Good luck and happy trading friends...
*3x lucky 7s of trading*
7pt Trading compass:
Price action, entry/exit
Volume average/direction
Trend, patterns, momentum
Newsworthy current events
Revenue
Earnings
Balance sheet
7 Common mistakes:
+5% portfolio trades, capital risk management
Beware of analysts motives
Emotions & Opinions
FOMO : bad timing
Lack of planning & discipline
Forgetting restraint
Obdurate repetitive errors, no adaptation
7 Important tools:
Trading View app!, Brokerage UI
Accurate indicators & settings
Wide screen monitor/s
Trading log (pencil & graph paper)
Big organized desk
Reading books, playing chess
Sorted watch-list
Checkout my indicators:
Fibonacci VIP - volume
Fibonacci MA7 - price
pi RSI - trend momentum
TTC - trend channel
AlertiT - notification
www.tradingview.com
$MRNA Target $170.40I've had some awesome readings on MRNA, so gonna document this one. I do dowsing and today (12/23) is a date for it, so usually when this occurs it's a reversal indication. So far, it's dropping well right out the gate and down 5%.
The suggestion is it drops to $170.40. That would also fill the gap below on the daily chart. We'll see!
I should note my upside target of $213 (from in Nov.) was hit, so makes sense it has some kind of drop.
$MRNA - Moderna: Megaphone TopOn weekly we can see that the price has formed a long-term Head&Shoulder, where its right shoulder is a Megaphone Top.
Price is hugging & kissing its upper trendline, which is also an area of a perfect entry to go SHORT, as there is a very small risk compare to a very big reward.
I will be looking and patiently waiting for a Key Reversal from upper trendline to go SHORT.
MRNA Overbought Condition with Daily Bearish Wolfe wave SetupThere is a daily wolfe wave setup that triggered on December 15. Today at the open, MRNA opened inside day and traded +4% within 30 mins of the trading day. The projected target is calculated by extending a linear line between pivot 1 and 4 and projecting the line; however, the linear lines do not converge. The projected target is approx 167 which is represented as the red perforated line. The target price coincides with the 50 day ma as shown in the chart. Using the customizable gap finder indicator there is a larget gap left open from the Dec 12 kicker. It is likely to fill the gap within 2 weeks time.
A Shot in the Arm for Moderna?Back at it again here folks,
Seems like MRNA is forming a nice flag pole pattern.
Today's price action hit the previous high of around 204 and then retreated slightly (as expected). It is also good to see that these sharp price increases were influenced by higher volume. I believe this will hold and continue to make higher highs, but we will see.
I have a conservative price target of about 225 with room to go higher. This is on a lower timeframe (2 hours) versus daily or weekly which could give some hesitancy since it is better and more reliable to see these patterns play out on a higher timeframe (to minimize fake outs).
Again, I know that I know nothing. This could take longer to play out or go against me, given that this pattern is playing out on a lower timeframe. But, I got in on this earlier today and am still holding because I like what I am seeing and had a strong day despite the choppy trading day today (QQQ for example).
MRNA being a good market sell?Moderna - 30d expiry - We look to Sell at 186.88 (stop at 198.38)
Price action continued to range between key support & resistance (120 - 190) and we expect this to continue.
Daily signals are mildly bearish.
Posted a Double Top formation.
An Evening Doji Star formation has been posted at the high.
We look for a temporary move higher.
Offers ample risk/reward to sell at the market.
Our profit targets will be 158.11 and 150.11
Resistance: 190.00 / 197.44 / 210.00
Support: 180.00 / 170.00 / 160.00
Daily chart
Disclaimer – Saxo Bank Group.
Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis , like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis , as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features.
Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
MRNA IDEA HELLO GUYS THIS MY IDEA 💡ABOUT MRNA is nice to see strong volume area....
Where is lot of contract accumulated..
I thing that the buyers from this area will be defend this LONG position..
and when the price come back to this area, strong buyers will be push up the market again..
UP TREND + Resistance from the past + Strong volume area is my mainly reason for this long trade..
IF you like my work please like and follow thanks
MRNA - Long OpportunityTechnical Analysis:
- Cup and handle pattern signals bullish strength
- Price breaks above 200 MA, we can use 200 MA as our stop loss
- Price stayed resilient despite the SPY ending deep in the red on 15 Dec 2022
Catalyst:
- Cancer mRNA vaccine completed pivotal trial (www.bbc.com). For pharmaceutical stocks, successful trials and FDA approvals act as very strong catalyst that can boost the stock significantly. Conversely, trial failures can crash the stock. The market for mRNA vaccine is expected to grow 130% by 2028 from 2021.
Entry: 208.72
Stop Loss; 156.6
Take Profit Target: 291 (If this goes well, I will take profit on 1/2 position and let the other 1/2 run)